Office of Policy, Legislation, and International Affairs
Effective March 31, 2019, FDA began operational implementation of an agency reorganization. FDA’s reorganization reflects the agency’s commitment to modernizing its structure to advance its mission to protect and promote public health, and to meet the challenges of rapid innovation across the industries regulated by FDA. FDA's reorganization realigns several entities across the agency to promote strategic priorities, and elevates the role of the centers, offices and field forces.
This organization chart reflects the new structure.
Andi Lipstein Fristedt
Deputy Commissioner
Beethika Khan, Ph.D.
Associate Commissioner for Economics and Analysis
Office of Economics and Analysis
Andrew Tantillo, J.D.
Acting Associate Commissioner for Legislative Affairs
Office of Legislation
Maren McBride
Director of Congressional Appropriations
Office of Congressional Appropriations
Mark Abdoo
Associate Commissioner for Global Policy and Strategy
Office of Global Policy and Strategy
Lauren Roth, J.D.
Associate Commissioner for Policy
Office of Policy
Linda Fobbs
Director of Management and Operations
Management and Operations Staff
Nicholas Alexander, J.D.
Director of Intergovernmental Affairs
Intergovernmental Affairs Staff